Thrombin activity throughout the acute phase of acute ST-elevation myocardial infarction and the relation to outcome

Biomarkers

Volumn 14, Issue 5, 2009, Pages 311-316

  Ulrich Mckel, Natalie Viviane ^a   Riehle, Matthias ^b   Vollert, Jrn ^a   Heller Jr , Gnther ^c   Strk, Thomas ^d   Riess, Hanno ^a   Mller, Christian ^a   Frei, Ulrich ^a   Möckel, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c AOK Research Institute   (Germany)

^d OLGAHOSPITAL   (Germany)

Author keywords

Major cardiac events; Reperfusion therapy; STEMI; Thrombin

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN III; PLASMIN; PROTHROMBIN; THROMBIN; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CONVENTIONAL ANGIOGRAPHY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; REVASCULARIZATION; ST SEGMENT ELEVATION; BLOOD; ENZYMOLOGY; HEART INFARCTION; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMIN; THROMBIN; TREATMENT OUTCOME;

EID: 70149095695     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902878737     Document Type: Article

References (24)

1. Agnelli G. (1996). Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis. CardiovascRes 31:232-234
2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, and others. 2004. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110:588-636.
3. Bode W. (2006). The structure of thrombin: A janus-headed proteinase. Semin Thromb Hemost 32 (Suppl. 1):16-31.
4. Brener SJ, Barr LA, Burchenal JEB, Katz S, George BS, Jones AA, Cohen ED, Gainey PC, White H J, Cheek H B, and others. (1998). Randomized placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 98:734-741
5. Christersson C, Oldgren J, Bylock A, Siegbahn A, Wallentin L. (2007). Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM trial. Eur Heart J 28:692-698 (Pubitemid 46439238)
6. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. (1986). Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73:418-427
7. Faxon DP, Heger JW. (1999) Primary angioplasty - enduring the test of time. N Engl J Med 341:1464-1465
8. Goto S, Kawai Y, Abe S, Takahashi E, Handa S, Ogawa S, Watanabe K, Hori S, Ikeda Y. (1994). Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction. Angiology 45:273-281
9. Gulba DC, Barthels M, Reil GH, Lichtlen PR. (1988). Thrombin/ antithrombin-III complex level as early predictor of reocclusion after successful thrombolysis. Lancet 2:97.
10. Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Rafflenbeul W, Daniel WG, Hecker H, Lichtlen PR. (1991). Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation 83:937-944
11. GUSTO Angiographic Investigators. (1993). The effects of tissue plasminogen activator streptokinase or both on coronary-artery patency ventricular function and survival after acute myocardial infarction. N Engl J Med 329:1615-1622
12. Huisse MG, Lanoy E, Tcheche D, Feldman LJ, Bezeaud A, Angles- Cano E, Mary-Krause M, de Prost D, Guillin MC, Steg PG. (2007). Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction. Thromb Haemost 98:420-426
13. Kimura M, Andersen TT, Fenton JW, Bahou WF, Aviv A. (1996). Plasmin-platelet interaction inves cleavage of functional thrombin receptor. Am J Physiol Cell Physiol 271:C54-60.
14. Mockel M, Ulrich NV, Heller G Jr, Rocker L, Hansen R, Riess H, Patscheke H, Stork T, Frei U, Ruf A. (2001). Platelet activation through triathlon competition in ultra-endurance trained athletes: Impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med 22:337-343
15. Mockel M, Ulrich NV, Rocker L, Ruf A, Klefisch F,Patscheke H, Eichstadt H, Stork T, Frei U. (1999). Exhaustive cycle exercise induces P-selectin expression coagulation and fibrinolysis activation in ultraendurance athletes. Thromb Res 94:263-269
16. Moser M, Nordt T, Peter K, Ruef J, Kohler B, Schmittner M, Smalling R, Kubler W, Bode C. (1999). Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase alteplase or streptokinase. Circulation 100:1858-1864
17. Nordt TK, Moser M, Kohler B, Ruef J, Peter K, Kubler W, Bode C. (1998). Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction. Thromb Haemost 80:881-886
18. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. (1999). Effects of recombinant hirudin (lepirudin) compared with heparin on death myocardial infarction refractory angina and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet 353:429-438
19. Schwienhorst A. (2006). Direct thrombin inhibitors - a survey of recent developments. Cell Mol Life Sci (CMLS) 63:2773-2791
20. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. (2008). Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358:2218-2230
21. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, and others. (2006). Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355:2203-2216
22. van der Putten RFM, Glatz JFC, Hermens WT. (2006). Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta 371:37-54.
23. Vermeer F, Ophuis AJMO, Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, Lousberg AH, Dassen WR, Bar FW. (1999). Prospective randomised comparison between thrombolysis rescue PTCA and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: A safety and feasibility study. Heart 82:426-431
24. Zijlstra F, Hoorntje JCA, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, 't Hof AWJ, Suryapranata H. (1999). Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341:1413-19. (Pubitemid 29513456)